Baywater Healthcare is an independent specialist provider of healthcare services. It supports more than 27,500 patients with long term conditions, delivering high-quality, cost-effective solutions while helping patients maintain their mobility, independence and overall quality of life.
The Company’s range of healthcare services includes home oxygen therapy, sleep diagnostics, CPAP (Continuous Positive Airway Pressure) treatment and adherence management, telehealth through remote monitoring, ventilation therapy, nebuliser therapy and emergency oxygen.
Souter Investments backed the acquisition of Baywater Healthcare from Air Products in 2013, in a deal arranged by Duke Street.
In August 2015, Baywater Healthcare disposed of its market leading Irish business to Air Liquide.
Now focussed on its core UK market, Baywater has secured extensions to its major client contracts and plans to grow further by winning major new contracts coming to the market in the near future, in addition to pursuing other new business development opportunities.